Results 261 to 270 of about 7,978,447 (307)
Metabolomic profiling refines cardiovascular risk stratification beyond SCORE2-diabetes in patients with concurrent type 2 diabetes and pulmonary dysfunction. [PDF]
Front Endocrinol (Lausanne)Li M, Shen Y, Huang Y, Liu L, Bin W.
europepmc +1 more source
MetCool ACS: study protocol for a multicentre quasi-randomised trial of metformin in patients without diabetes after acute coronary syndrome in Poland. [PDF]
BMJ OpenSutkowska E +3 more
europepmc +1 more source
Correction: Retrospective real-world database study to examine the prevalence and incidence of cardiovascular diseases and medication prescription in Japanese patients with type 2 diabetes. [PDF]
Diabetol IntKomatsu M +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Association of chronic venous disease with major adverse cardiovascular events
Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2022The aim of the present study was to examine whether severe chronic venous disease (CVD) is associated with a greater risk of major adverse cardiovascular events (MACE) compared with mild CVD.Participants with CVD were prospectively recruited from outpatient vascular departments at two hospitals in North Queensland, Australia.
Jonathan Golledge +2 more
exaly +4 more sources
Prediction of Adverse Events in Patients Undergoing Major Cardiovascular Procedures
IEEE Journal of Biomedical and Health Informatics, 2017Electronic health records (EHR) provide opportunities to leverage vast arrays of data to help prevent adverse events, improve patient outcomes, and reduce hospital costs. This paper develops a postoperative complications prediction system by extracting data from the EHR and creating features.
Bobak Mortazavi +6 more
openaire +2 more sources